Loading...

Purified anti-human CD29 Antibody

Pricing & Availability
Clone
TS2/16 (See other available formats)
Regulatory Status
RUO
Workshop
V A-S202
Other Names
Integrin β1 chain, VLA-β chain, gpIIa, ITGB1
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
TS216_Purified_062107
Human peripheral blood lymphocytes stained with purified TS2/16, followed by anti-mouse IgGs FITC
  • TS216_Purified_062107
    Human peripheral blood lymphocytes stained with purified TS2/16, followed by anti-mouse IgGs FITC
  • zTS2slash16_IF_072512
    BT474 breast cancer cells were stained with anti-CD29 (clone TS2/16) followed by DyLight™ 649 Goat anti-mouse Ig secondary antibody (red), plus DAPI staining for nuclei (blue). Images were taken under 20x bin4 (Filter set: EX647/10x, Dichroic 665LP, EM 700/70x) at exposure 4s. Data provided by Er Liu and John Nolan, La Jolla Institute for Bioengineering.
Compare all formats
Cat # Size Price Quantity Check Availability Save
303001 25 µg 59 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
303002 100 µg 112 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD29 is a 130 kD single chain type I glycoprotein also known as integrin β1, VLA-β chain, or gpIIa. It is broadly expressed on a majority of hematopoietic and non-hematopoietic cells, including leukocytes (although at low level on granulocytes), platelets, fibroblasts, endothelial cells, epithelial cells, and mast cells. CD29 is a member of the integrin family. It is non-covalently associated with integrin α1-α6 chains to form VLA-1 to VLA-6 molecules, respectively. Integrins, which include CD29, bind to several cell surface (e.g. VCAM-1, MadCAM-1) and extracellular matrix molecules. CD29 acts as a fibronectin receptor and is involved in a variety of cell-cell and cell-matrix interactions.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
African Green, Baboon, Cow, Cynomolgus, Dog, Horse, Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
ICC - Verified
IHC, IP - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per 106 cells in 100 µL volume or 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen tissue sections3,5, and activation of integrin ß14,7,8. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 303010). Clone TS2/16 recognizes epitope A2.10

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Gutierrez-Lopez M, et al. 2003. J. Biol. Chem. 278:208.
  3. Hemler ME, et al. 1984. J. Immunol. 132:3011. (IHC, IP)
  4. Sanchez-Aparicio P, et al. 1994. J. Cell Biol. 126:271. (Activ)
  5. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC)
  6. Murga M, et al. 2005. Blood 105:1992. (FC) PubMed
  7. Porter JC and Hogg N. 1997. J. Cell Biol. 138:1437. (Activ)
  8. Conway RE, et al. 2006. Mol. Cell. Biol. 26:5310. (Activ)
  9. Wesseling J, et al. 1995. J. Cell. Biol. 129:255. (Dog Reactivity)
  10. Rubio G, et al. 2002. Cancer Immunol. Immunother. 51:130.
  11. Dong A, et al. 2015. J Biol Chem. 290:8016. PubMed
  12. Paebst F, et al. 2014. Cytometry A. 85(8):678-87. (Horse reactivity)
Product Citations
  1. Mendt M, et al. 2018. JCI Insight. 9:1523. PubMed
  2. Ceccarelli S, et al. 2022. Front Cell Dev Biol. 10:926180. PubMed
  3. Friedman D, et al. 2021. J Cell Sci. 134:. PubMed
  4. Pilbauerova N, et al. 2021. Int J Mol Sci. 22:. PubMed
  5. Sivasubramaniyan K, et al. 2015. Glycobiology. 25: 902-917. PubMed
  6. Pillozzi S, et al. 2011. Blood. 117:902. PubMed
  7. Kaufmann M, et al. 2021. Med. 2(3):296-312.e8. PubMed
  8. Novoseletskaya E, et al. 2020. Front Cell Dev Biol. 8:555378. PubMed
  9. Horwacik I, et al. 2017. Int J Oncol. 50:1899. PubMed
  10. Blázquez-Prunera A, et al. 2017. Stem Cell Res Ther. 10.1186/s13287-017-0552-z. PubMed
  11. Zhang X, et al. 2011. Am J Physiol Cell Physiol. 301:1017. PubMed
  12. Cho YY, et al. 2019. PLoS One. 14:e0210535. PubMed
  13. Olin A, et al. 2018. Cell. 174:1277. PubMed
  14. Eccles JD, et al. 2020. Cell Rep. 30:351. PubMed
  15. Henrick BM, et al. 2021. Cell. . PubMed
  16. Tanigawa K, et al. 2019. J Cell Physiol. 234:17280. PubMed
  17. Freeman SA, et al. 2020. Science. 367:301. PubMed
  18. Rogers MA, et al. 2022. Front Cardiovasc Med. 9:778919. PubMed
  19. Conway R, et al. 2006. Mol Cell Biol. 26:5310. PubMed
  20. Ran LJ, et al. 2018. Mol Med Rep. 18:723. PubMed
  21. Dong A, et al. 2015. J Biol Chem. 290:8016. PubMed
RRID
AB_314317 (BioLegend Cat. No. 303001)
AB_314317 (BioLegend Cat. No. 303002)

Antigen Details

Structure
Integrin, type I glycoprotein, forms VLA-1 to VLA-6 heterodimers with CD49a-f (α1-α6), also associates with CD51 (αV), and α7- α9, 130 kD
Distribution

Lymphocytes, monocytes, granulocytes (low), platelets, mast cells, fibroblasts, endothelial cells

Function
Cell-cell and cell-matrix interactions
Ligand/Receptor
VCAM-1, MAdCAM-1, ECM
Cell Type
Embryonic Stem Cells, Endothelial cells, Fibroblasts, Granulocytes, Lymphocytes, Mast cells, Mesenchymal Stem Cells, Monocytes, Platelets, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Innate Immunity, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Hemler M. 1990. Annu. Rev. Immunol. 8:365.
2. Hynes R. 1992. Cell 69:11.

Gene ID
3688 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD29
Specificity Alt (DOES NOT SHOW ON TDS):
CD29
App Abbreviation (DOES NOT SHOW ON TDS):
FC,ICC,IHC,IP
UniProt
View information about CD29 on UniProt.org
Go To Top Version: 7    Revision Date: 08.31.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account